000 01183 a2200349 4500
005 20250514065844.0
264 0 _c20030916
008 200309s 0 0 eng d
022 _a1170-229X
024 7 _a10.2165/00002512-200320070-00005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMatz, Rachel L
245 0 0 _aAge-related endothelial dysfunction : potential implications for pharmacotherapy.
_h[electronic resource]
260 _bDrugs & aging
_c2003
300 _a527-50 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdult
650 0 4 _aAging
_xpathology
650 0 4 _aAnimals
650 0 4 _aEndothelium, Vascular
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypolipidemic Agents
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNitric Oxide
_xphysiology
650 0 4 _aVascular Diseases
_xdrug therapy
650 0 4 _aVasodilator Agents
_xtherapeutic use
700 1 _aAndriantsitohaina, Ramaroson
773 0 _tDrugs & aging
_gvol. 20
_gno. 7
_gp. 527-50
856 4 0 _uhttps://doi.org/10.2165/00002512-200320070-00005
_zAvailable from publisher's website
999 _c12538088
_d12538088